Compare LZB & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LZB | IART |
|---|---|---|
| Founded | 1927 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | N/A | 1995 |
| Metric | LZB | IART |
|---|---|---|
| Price | $38.68 | $13.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | ★ $42.50 | $15.00 |
| AVG Volume (30 Days) | 676.2K | ★ 807.9K |
| Earning Date | 11-18-2025 | 10-30-2025 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.16 | N/A |
| Revenue | ★ $2,107,357,000.00 | $1,642,966,000.00 |
| Revenue This Year | $2.36 | $3.26 |
| Revenue Next Year | $3.57 | $2.71 |
| P/E Ratio | $17.79 | ★ N/A |
| Revenue Growth | 1.78 | ★ 4.99 |
| 52 Week Low | $29.03 | $10.87 |
| 52 Week High | $48.31 | $27.13 |
| Indicator | LZB | IART |
|---|---|---|
| Relative Strength Index (RSI) | 63.24 | 54.02 |
| Support Level | $38.67 | $12.81 |
| Resistance Level | $40.75 | $13.82 |
| Average True Range (ATR) | 1.18 | 0.57 |
| MACD | 0.12 | 0.17 |
| Stochastic Oscillator | 68.58 | 80.41 |
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.